Recognition of 5'-terminal TAR Structure in Human Immunodeficiency Virus-1 MRNA by Eukaryotic Translation Initiation Factor 2

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2000 Jan 29

PMID 10648795

Citations 10

Authors

Y Banai

H Hauser

R KAEMPFER

Affiliations

Soon will be listed here.

Abstract

TAR, a 59 nt 5'-terminal hairpin in human immuno-deficiency virus 1 (HIV-1) mRNA, binds viral Tat and several cellular proteins. We report that eukaryotic translation initiation factor 2 (eIF2) recognizes TAR. TAR and the AUG initiation codon domain, located well downstream from TAR, both contribute to the affinity of HIV-1 mRNA for eIF2. The affinity of TAR for eIF2 was insensitive to lower stem mutations that modify sequence and structure or to sequence changes throughout the remainder that leave the TAR secondary structure intact. Hence, eIF2 recognizes structure rather than sequence in TAR. The affinity for eIF2 was severely reduced by a 3 nt change that converts the single A bulge into a 7 nt internal loop. T1 footprinting showed that eIF2 protects nucleotides in the loop as well as in the strand opposite the A bulge. Thus, eIF2 recognizes the TAR loop and lower part of the sub-apical stem. Though not contiguous, these regions are brought into proximity in TAR by a bend in the helical structure induced by the UCU bulge; binding of eIF2 opens up the bulge context and apical stem. The ability to bind eIF2 suggests a function for TAR in HIV-1 mRNA translation. Indeed, the 3 nt change that reduces the affinity of TAR for eIF2 impairs the ability of reporter mRNA to compete in translation. Interaction of TAR with eIF2 thus allows HIV-1 mRNA to compete more effectively during protein synthesis.

Citing Articles

Positive Regulation of Splicing of Cellular and Viral mRNA by Intragenic RNA Elements That Activate the Stress Kinase PKR, an Antiviral Mechanism.

Kaempfer R Genes (Basel). 2023; 14(5).

PMID: 37239334 PMC: 10218296. DOI: 10.3390/genes14050974.

HIV co-opts a cellular antiviral mechanism, activation of stress kinase PKR by its RNA, to enable splicing of rev/tat mRNA.

Namer L, Harwig A, Heynen S, Das A, Berkhout B, Kaempfer R Cell Biosci. 2023; 13(1):28.

PMID: 36774495 PMC: 9922466. DOI: 10.1186/s13578-023-00972-1.

PKR activation and eIF2α phosphorylation mediate human globin mRNA splicing at spliceosome assembly.

Ilan L, Osman F, Namer L, Eliahu E, Cohen-Chalamish S, Ben-Asouli Y Cell Res. 2017; 27(5):688-704.

PMID: 28374749 PMC: 5520854. DOI: 10.1038/cr.2017.39.

Network-based prediction and analysis of HIV dependency factors.

Murali T, Dyer M, Badger D, Tyler B, Katze M PLoS Comput Biol. 2011; 7(9):e1002164.

PMID: 21966263 PMC: 3178628. DOI: 10.1371/journal.pcbi.1002164.

RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region.

James L, Sargueil B Nucleic Acids Res. 2008; 36(14):4653-66.

PMID: 18625613 PMC: 2504303. DOI: 10.1093/nar/gkn447.

References

Weeks K, Crothers D . RNA recognition by Tat-derived peptides: interaction in the major groove?. Cell. 1991; 66(3):577-88. DOI: 10.1016/0092-8674(81)90020-9. View

Maitra R, McMillan N, Desai S, McSwiggen J, Hovanessian A, Sen G . HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 1994; 204(2):823-7. DOI: 10.1006/viro.1994.1601. View

Wei P, Garber M, Fang S, Fischer W, Jones K . A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998; 92(4):451-62. DOI: 10.1016/s0092-8674(00)80939-3. View

Donahue T, Cigan A, Pabich E, Valavicius B . Mutations at a Zn(II) finger motif in the yeast eIF-2 beta gene alter ribosomal start-site selection during the scanning process. Cell. 1988; 54(5):621-32. DOI: 10.1016/s0092-8674(88)80006-0. View

Garber M, Jones K . HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol. 1999; 11(4):460-5. DOI: 10.1016/S0952-7915(99)80077-6. View

Parkin N, Cohen E, Darveau A, Rosen C, Haseltine W, Sonenberg N . Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J. 1988; 7(9):2831-7. PMC: 457075. DOI: 10.1002/j.1460-2075.1988.tb03139.x. View

Jones K, Peterlin B . Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem. 1994; 63:717-43. DOI: 10.1146/annurev.bi.63.070194.003441. View

Karn J, Varani G . Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res. 1996; 24(20):3974-81. PMC: 146214. DOI: 10.1093/nar/24.20.3974. View

Scheper G, Thomas A, VOORMA H . The 5' untranslated region of encephalomyocarditis virus contains a sequence for very efficient binding of eukaryotic initiation factor eIF-2/2B. Biochim Biophys Acta. 1991; 1089(2):220-6. DOI: 10.1016/0167-4781(91)90011-a. View

10.

Darlix J, Gabus C, Nugeyre M, Clavel F, Barre-Sinoussi F . Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol. 1990; 216(3):689-99. DOI: 10.1016/0022-2836(90)90392-Y. View

11.

Delling U, Reid L, Barnett R, Ma M, Climie S, Sonenberg N . Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. J Virol. 1992; 66(5):3018-25. PMC: 241061. DOI: 10.1128/JVI.66.5.3018-3025.1992. View

12.

Rothblum C, Jackman J, Mikovits J, Shukla R, Kumar A . Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes. J Virol. 1995; 69(8):5156-63. PMC: 189338. DOI: 10.1128/JVI.69.8.5156-5163.1995. View

13.

Gonsky R, Lebendiker M, Harary R, Banai Y, KAEMPFER R . Binding of ATP to eukaryotic initiation factor 2. Differential modulation of mRNA-binding activity and GTP-dependent binding of methionyl-tRNAMetf. J Biol Chem. 1990; 265(16):9083-9. View

14.

Lane W, Gaynor R . The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA. EMBO J. 1995; 14(23):5995-6009. PMC: 394719. DOI: 10.1002/j.1460-2075.1995.tb00288.x. View

15.

Laurino J, Thompson G, Pacheco E, Castilho B . The beta subunit of eukaryotic translation initiation factor 2 binds mRNA through the lysine repeats and a region comprising the C2-C2 motif. Mol Cell Biol. 1998; 19(1):173-81. PMC: 83876. DOI: 10.1128/MCB.19.1.173. View

16.

KAEMPFER R, Hollender R, Abrams W, Israeli R . Specific binding of messenger RNA and methionyl-tRNAfMet by the same initiation factor for eukaryotic protein synthesis. Proc Natl Acad Sci U S A. 1978; 75(1):209-13. PMC: 411215. DOI: 10.1073/pnas.75.1.209. View

17.

Colvin R, Garcia-Blanco M . Unusual structure of the human immunodeficiency virus type 1 trans-activation response element. J Virol. 1992; 66(2):930-5. PMC: 240794. DOI: 10.1128/JVI.66.2.930-935.1992. View

18.

KAEMPFER R, van Emmelo J, Fiers W . Specific binding of eukaryotic initiation factor 2 to satellite tobacco necrosis virus RNA at a 5'-terminal sequence comprising the ribosome binding site. Proc Natl Acad Sci U S A. 1981; 78(3):1542-6. PMC: 319167. DOI: 10.1073/pnas.78.3.1542. View

19.

Brand S, Kobayashi R, Mathews M . The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem. 1997; 272(13):8388-95. DOI: 10.1074/jbc.272.13.8388. View

20.

Gatignol A, Buckler-White A, Berkhout B, Jeang K . Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science. 1991; 251(5001):1597-600. DOI: 10.1126/science.2011739. View